5th API Task Force Meet discusses coronavirus (COVID-19), drugs, medicine & pharma

New Delhi: Keeping in view the country’s over dependence on import of Active Pharmaceutical Ingredients (APIs), the Union Government has constituted a Task Force on APIs under the chairmanship of Minister of State (MoS) for Shipping (I/C) and Chemicals & Fertilizers, Mansukh Mandaviya, to formulate a roadmap for the enhanced production of APIs in the country.

The Ministry of Chemicals and Fertilizers has announced that the 5th meeting of the Task Force was held yesterday, where several important issues were discussed regarding policy relaxations to small, medium, and large API units, and also simplification of the process for environment clearance for production and availability of medicines.

In the meeting, MoS Mansukh Mandaviya took stock of the situation of availability of drugs and medicines. The industry representatives explained to Mandaviya that they have enough drugs and medicines to deal with any contingency arising out of the impact of the novel coronavirus (COVID-19), and ensured that there will be no shortage of any drugs, APIs and medicines in the coming days in India.

During the meeting, the challenges faced by the pharmaceutical industry in obtaining environment clearances were also discussed. The representative of the Ministry of Environment and Forest, Climate Change (MoEFCC) stated that steps are being taken to expedite environment clearances, and also mentioned that MoEFCC recently modified the guidelines so that there is no need to obtain separate environment clearances if the production of the pharma unit is increased by 50%.

Follow Indus Dictum on Facebook, Twitter, and LinkedIn for the latest updates.

Subscribe to Indus Dictum to receive a briefing about the latest news & feature articles. No spam, we promise.

Success! You're on the list.

The ID Staff

Daily stories by the Indus Dictum Staff

Have some feedback for the author? Click here to comment.